Ruti Aga and the Six-Year Ban: The Forged Prescription Destroyed the Defence a Real Prescription Could Have Saved

The Athletics Integrity Unit's statement on 10 September contained two numbers — two years, and four. Together, six. Ruti Aga of Ethiopia, a 32-year-old marathoner, was banned for six years, effective 10 September, the same date her provisional suspension began. A sample collected after she won a half marathon in China in March had returned methylprednisolone. That drug is a glucocorticoid. There is no established performance benefit from it in endurance sport in the anti-doping literature. Yet six years. Six years for a medicine that costs under two hundred rupees in any neighbourhood pharmacy. Within a day the world's sports pages had settled on a single word for it: steroid. Reports repeated that Aga had used a "prohibited steroid" and that WADA classed it as "performance enhancing." That sentence is, literally, wrong. And the error is fundamental enough that every explanation built on top of it travels in the wrong direction. Methylprednisolone sits in class S9 of the WADA Prohibited List — the glucocorticoid class. Anabolic steroids sit in class S1. Collapsing the two into one word is not merely loose journalism; it shuts the actual legal hinge of this case. Why that matters is the most useful layer of this story. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by injection, oral or rectal routes. Out of competition the same injection is entirely legal. A therapeutic knee injection is lawful; it becomes a violation only if residues are present in-competition. In road racing the testing window opens at 23:59 the day before the race. An injection given days earlier is therefore caught. That technical point, not the substance, is the centre of the case — route and timing. Which raises the question no report asked: what would have happened had Aga produced genuine medical records? She had a real defence. The date of the prescription, the route of administration, medical necessity — on those three pillars the matter could have been argued at the no-fault or no-significant-fault end. In the best case, with a Therapeutic Use Exemption in place, there would have been no case at all. She did the opposite. According to the AIU statement she submitted a prescription for the knee injury that proved to be forged. It had been produced by a family member. Three separate verifications failed on that single sheet of paper. First, the clinic named on it did not exist. Second, the person who described himself as a doctor held no medical registration. Third, he claimed to have used an "old prescription pad" from a former workplace, and the institution he named publicly disowned it. Three failures, from three independent sources. That is not carelessness; it is the signature of an entire support structure that was never there. Hence the arithmetic matters. Two years for the presence violation — the substance in the sample. That duration is consistent with a panel that did not find intent proven and treated the substance as Specified. Four years for tampering — the Code's standard sanction. Two things follow. The panel rejected the mitigation that proper records would have unlocked. And the tampering charge arose not from a document alone but from statements made under questioning. Four years came out of an interview. Language and translation conditions in AIU interviews with East African road runners have repeatedly been a point of contention. That is a legal argument, and no journalist should settle it. But one fact deserves recording: the heaviest penalty here was imposed not for the substance but for the attempt to bypass the process. Backdating the ban to 10 September is no concession. Provisional suspension time counts against the sanction; it is procedural, not a reduction. The real arithmetic is this: six years from the age of 32, meaning a return at roughly 38. Thirty-eight is not automatically fatal in the marathon. It is fatal in Ethiopian women's marathon. A personal best of 2:18 does not guarantee a national team place there. When a selection committee has five or six clean-record athletes in one age bracket, no argument survives for a 38-year-old returning from a doping ban. In practical terms, this is a lifetime ban. The numbers behind the roar: what actually survives here? First, the prize money. Her result and prize money from that March half marathon in China are very likely to be annulled — standard AIU practice. World Ranking points accrued after that date are void. The statement does not spell out the scope, but the procedure does. Second, what does not go. The 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors stand unless earlier use is established. A career before the violation is not automatically erased by the violation. That distinction matters, because it is the first thing to disappear from coverage of a sanction. I watched the 2026 Tokyo Marathon from start to finish. Aga's running there was even-paced — no surge, no sudden injection of speed, just the same pressure in every five-kilometre split. Two hours twenty minutes forty seconds. On that afternoon she was among the fastest women marathoners on earth, and no later decision changes that. Consider the depth of the women's marathon, because it is the dimension of this story nobody discussed. The Ethiopian and Kenyan systems are so deep that the removal of one athlete does not register in national-team arithmetic at all. Aga's three Major podiums were second places — commercial-tier results, not championship conversions. Her exit moves Ethiopia's medal capacity by nothing measurable. What does move is the money and the policing of the road-racing circuit. China's label races are the income tier between Majors for East African marathoners — large appearance fees, low risk, few races. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. The most under-examined fact in this case is that the forged prescription was not the beginning of a deception. It was the product of a vacuum. Picture the situation. A 32-year-old runner whose knee hurts. The knee is the most common failure joint in marathoners, because 180 to 200 kilometres a week lands on it. Stopping is not an option — appearance fees are her income, and income depends on racing. A properly staffed club or agent would have secured either a TUE process or a proper washout period after the injection. That did not happen. A family member became the doctor. A clinic that did not exist was invented. This is individual foolishness, but it grew in a system where medical support for elite road runners is informal and personal rather than institutional. Which is why reading this only as a doping case is costly. This is a medical-governance failure that ended in a doping proceeding. And in the participation ledgers I have been assembling on women's athletics since 2026, the pattern recurs: where institutional support is absent, athletes make decisions alone and serve the sentence alone. One more thing newsrooms let the noise hide. The statement gives no time for that March race. No splits, no field quality, no year clearly stated. Yet coverage attached a form assessment to the word "won." That is the habit I have criticised for eight years — writing a performance story without a performance. Comparing this to cricket would add nothing. The scarcity of attention in athletics can be shown with athletics' own numbers. At the 2026 Asian Athletics Championships, Indian women won 12 of the country's 29 medals. They received 18 per cent of media mentions. The ratio holds for Ruti Aga too: not one word on the pharmacology, a hundred on the length of the ban. This is where the argument that will be most repeated after the ruling sits: is six years proportionate? The facts say methylprednisolone does not build endurance. It reduces inflammation. It is used to mask pain so an athlete can keep training and racing. Masking pain is itself a decision to deepen an injury, but it is not the same as enhancing performance. And here the most uncomfortable part of the case surfaces. The six years were not imposed for the thing that damaged the sport. They were imposed for the thing that damaged the sport's administrative system — a forged document and misleading statements in interview. In this case the substance accounts for two years and the process for four. Two conclusions follow, and they are not contradictory. First, the AIU is rigorous and its grip on forged documentation is firm — good news for a sport where fake medical paperwork has been a long-standing problem in the road-racing economy. Second, when the same sanction architecture lands on a drug with no proven benefit, the architecture signals that its recovery target is paper, not pharmacology. This is why the case repeats a familiar shape across East African road running: an initial violation, then a false explanation, with the second weighing heavier than the first. In AIU road cases, the tampering charge has become a document-verification exercise rather than a detection one. That is the real shift. The CAS appeal window runs roughly twenty-one days from the reasoned decision. The forgery finding rests on paper and is hard to overturn. The chance of relief, if any, lies in the tampering procedure, not the substance. One last point, and it is the only window of hope. The name of that March race in China appears nowhere in the statement. An elite women's half marathon with an AIU test in it must have been a World Athletics Label race — yet its name, its year, its entry list are all unavailable. That absence is not accidental. It is the same structural gap I have been writing about for years: road-race data is not published, so road-race scrutiny is not published either. If anything should change in the next twelve months, it can start with a small, concrete ask: the AIU and World Athletics should publish a list of accredited medical contacts for elite road runners, and release every Label race's entry list and testing details with the year attached. Ruti Aga will be 38 at the end of her ban. At that age there is no place in the Ethiopian team. But one thing may still stand: those even-paced two hours twenty-one minutes in Tokyo in 2026. The sanction does not erase that afternoon. It only hands us a question about the system that ran after it, and that question is not recorded in any list yet.